Letters Related to Dr. Lowe's
Rebuttal to the British Thyroid Association |
Want to be notified about new publications in
Thyroid Science? |
|
|
Letters below are posted in
descending order. The first letter below has the earliest date,
and the last one has the latest date.
To submit a letter to an editor
or author through Thyroid Science, please read our
guidelines
for submitting letters. Submit your letter to
Editor@thyroidscience.com.
Letters may be edited and shortened. Thank you.
|
General Letters |
Dr. Allahabadia's Reply |
Subject: Reply
to rebuttal to the BTA's opinions
From:
editor@thyroidscience.com
Date: Mon, March 15, 2010 9:01 am
To:
Amit.Allahabadia@sth.nhs.uk
Secretary, British Thyroid Association
-----------------------------------------
Dear Dr. Allahabadia,
I initially wrote to you in March 16, 2009—one year ago—asking
that the
British Thyroid Association (BTA) respond to my rebuttal
<http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm>
to its opinions on levothyroxine, T4/T3 combination therapy, and
desiccated
thyroid. You wrote back to me in August 2009 saying that the BTA
would
respond “in due course.”
I consider that due course has long since passed. If the BTA
does not
enter discourse over its opinions, then its opinions can
justifiably be
considered authoritative and dogmatic rather than rational and
scientifically-based.
I request once more that the BTA reply to the various points in
my
rebuttal. Considering how long it has been since I initially
wrote to the
BTA, a prompt response from the BTA is imperative. The reason is
that many
practitioners are likely to accept without question that the
BTA’s
opinions are scientifically accurate. Because some of the BTA’s
opinions,
expressed in its Executive Committee’s document, are patently
false, which
I documented in my rebuttal, some of these practitioners may
make
decisions on behalf of hypothyroid patients that adversely
affect the
health and well-fare of hypothyroid patients.
It is in the interest of quality care for hypothyroid patients,
and in the
spirit of traditional scientific values, that I ask again that
the BTA to
reply to my rebuttal.
Sincerely,
Dr. John C. Lowe
Editor-in-Chief
Thyroid Science
Subject:
RE: Request for reply from the
British Thyroid Association From:
Amit.Allahabadia@sth.nhs.uk
Date: Tue, April 7, 2009 4:22 am To:
editor@thyroidscience.com
Dear Dr Lowe
Thank you for e-mail.
The Executive Committee of the British Thyroid
Association will consider your comments in due course in
consultation with The Royal College of Physicians.
Best wishes Dr Amit Allahabadia Secretary of The
British Thyroid Association
Subject:
Request for reply from the British Thyroid Association From:
editor@thyroidscience.com Date: Tue,
April 7, 2009 4:11 am To: Amit.Allahabadia@sth.nhs.uk
To: Dr Amit Allahabadia Secretary: British Thyroid
Association Sheffield Teaching Hospitals, Sheffield
Dear Dr. Allahabadia,
Below is an email I send to
you and the British Thyroid Association (BTA) on March 16,
2009. In the email, I invited a response from the BTA to be
published without censorship at Thyroid Science in the
spirit of scientific discourse. I have not received a
response from you or from any other representative of the BTA.
I will be grateful if you or another representative will give
us the courtesy of letting us know, at minimum, that you
received my email, but hopefully also letting us know whether we
can expect a response from the BTA. Thank you for taking the
time to reply.
For your convenience, below is the webpage address to my
rebuttal to the BTA's document on natural desiccated thyroid
and synthetic T4/T3 therapies:
http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm
Best regards, Dr. John C. Lowe Board Certified: American
Academy of Pain Management Director of Research: Fibromyalgia
Research Foundation Editor-in-Chief: ThyroidScience.com
(603) 391-6061,
www.drlowe.com
drlowe@drlowe.com
Tammy@drlowe.com
drlowe@FibromyalgiaResearch.org
Subject: Rebuttal to
British
Thyroid Association's document on natural desiccated
thyroid From:
editor@thyroidscience.com Date: Mon,
March 16, 2009 2:12 pm
To:
Amit.Allahabadia@sth.nhs.uk
To: Dr Amit Allahabadia Secretary: British Thyroid
Association Sheffield Teaching Hospitals, Sheffield
Dear Dr. Allahabadia,
I have included below a
link to a rebuttal I have written to the British Thyroid
Association (BTA). The rebuttal concerns the BTA Executive
Committee's 2007 document on natural desiccated thyroid and
levothyroxine. After having critically analyzed the
Committee's document, I believe it constitutes a gross
disservice to patients and clinicians who might read and be
mislead by its unbalanced presentation of evidence and the false
statements it contains. I feel it is proper to let the BTA know
about my rebuttal so that its officials can respond,
hopefully by correcting the misinformation the 2007 document
contains. We at
Thyroid Science, of course, will be happy to
publish any statement the BTA decide to make in response to
the rebuttal.
http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm
All best wishes,
Sincerely, Dr. John C. Lowe
Board Certified: American Academy of Pain Management Director
of Research: Fibromyalgia Research Foundation
Editor-in-Chief: ThyroidScience.com (603) 391-6061,
www.drlowe.com
drlowe@drlowe.com
Tammy@drlowe.com
drlowe@FibromyalgiaResearch.org |